| ASSET | QUARTER | % RETURN |
|---|---|---|
Gyre Therapeutics (GYRE) | Q2 2022 | 157.97% |
Belite Bio Inc ADR (BLTE) | Q2 2022 | 149.12% |
Yatsen (YSG) | Q2 2022 | 115.28% |
Compass Therapeutics (CMPX) | Q2 2022 | 96.3% |
Altimmune (ALT) | Q2 2022 | 92.12% |
Day One Biopharmaceuticals (DAWN) | Q2 2022 | 82.47% |
Innoviz Technologies (INVZW) | Q2 2022 | 73.53% |
SIGA Technologies (SIGA) | Q2 2022 | 72.84% |
Cango (CANG) | Q2 2022 | 68.05% |
Daqo New Energy Corp ADR (DQ) | Q2 2022 | 63.23% |
Amylyx Pharmaceuticals (AMLX) | Q2 2022 | 60.23% |
Wave Life Sciences (WVE) | Q2 2022 | 57.77% |
Valhi (VHI) | Q2 2022 | 55.74% |
Hallador Energy (HNRG) | Q2 2022 | 55.46% |
Ardmore Shpng (ASC) | Q2 2022 | 54.89% |
SunOpta (STKL) | Q2 2022 | 54.67% |
Dingdong ADR (DDL) | Q2 2022 | 47.07% |
NL Industries (NL) | Q2 2022 | 40.32% |
Oruka Therapeutics (ORKA) | Q2 2022 | 39.89% |
JinkoSolar (JKS) | Q2 2022 | 38.25% |
Annexon (ANNX) | Q2 2022 | 37.59% |
Genie Energy (GNE) | Q2 2022 | 35.68% |
Universal Logistics (ULH) | Q2 2022 | 35.02% |
Permian Basin Royalty Trust (PBT) | Q2 2022 | 34.53% |
Esperion Therapeutics (ESPR) | Q2 2022 | 34.18% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
